Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Case
-
Reference no. 9-899-292
Subject category: Entrepreneurship
Published by: Harvard Business Publishing
Originally published in: 1999
Version: 9 September 2003
Length: 22 pages
Data source: Field research

Abstract

This case presents a look at the early start-up phase and development of Advanced Inhalation Research (AIR), a company engaged in the development of a new drug-delivery technology. Focuses on the risks, the steps taken to manage it, and the manner in which the company was financed. Presents an offer to acquire the business, leading to the question of how to value such an early-stage company.
Location:
Size:
40 employees
Other setting(s):
1998

About

Abstract

This case presents a look at the early start-up phase and development of Advanced Inhalation Research (AIR), a company engaged in the development of a new drug-delivery technology. Focuses on the risks, the steps taken to manage it, and the manner in which the company was financed. Presents an offer to acquire the business, leading to the question of how to value such an early-stage company.

Settings

Location:
Size:
40 employees
Other setting(s):
1998

Related